Adrenal responsivity in normal aging and mild to moderate Alzheimer's disease

Biological Psychiatry

Volumn 43, Issue 6, 1998, Pages 401-407

  Rasmuson, Sigbritt ^a   Näsman, Birgitta ^a   Eriksson, Sture ^a   Carlström, Kjell ^b   Olsson, Tommy ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ACTH; Adrenal cortex; Alzheimer's disease; Androgens; Cortisol; Estrogen

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; HYDROCORTISONE;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ANDROGEN RELEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN TEST; DISEASE SEVERITY; FEMALE; HORMONE RESPONSE; HUMAN; HYDROCORTISONE RELEASE; MALE; PRIORITY JOURNAL;

ADRENAL CORTEX HORMONES; ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; AGED; AGING; ALZHEIMER DISEASE; FEMALE; HUMANS; KINETICS; MALE; REFERENCE VALUES;

EID: 0032521418     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00283-7     Document Type: Article

References (45)

1. Amsterdam JD, Maislin G, Gold P, Winokur A (1989): The assessment of abnormalities in hormonal responsiveness at multiple levels of the hypothalamic-pituitary-adrenocortical axis in depressive illness. Psychoneuroendocrinology 14:43-62.
2. The APA task force on laboratory tests in psychiatry (1987): The dexamethasone suppression test: an overview of its current status in psychiatry. Am J Psychiatry 144:1253-1262.
3. Baulieu EE (1991): Neurosteroids: a new function in the brain. Biol Cell 71:3-10.
4. Brody S, Carlström K, Lagrelius A, Lunell NO, Rosenborg L (1982): Adrenocortical steroids, bone mineral content and endometrial condition in postmenopausal women. Maturitas 4:113-122.
5. Burgess LH, Handa RJ (1992): Chronic estrogen-induced alterations in adrenocorticotropin and corticosterone secretion, and glucocorticoid receptor mediated function in female rats. Endocrinology 131:1261-1269.
6. Carlström K, Damber MG, Furuhjelm M, Joelsson I, Lunell NO, v Schoultz B (1979): Serum levels of total dehydroepiandrosterone and total estrone in postmenopausal women with special regard to carcinoma of the uterine corpus. Acta Obstet Gynecol Scand 58:179-181.
7. Cuckle H, Stone R, Smith D, Wald N, Brammer M, Hajimohammedreza I, et al (1990): Dehydroepiandrosterone sulphate in Alzheimer's disease. Lancet ii:449-450.
8. Davis KL, Davis BM, Greenwald BS, Mohs RC, Mathe' AA, Johns CS, et al (1986): Cortisol and Alzheimer's disease, 1: Basal studies. Am J Psychiatry 143:300-305.
9. Desjardins GC, Brawer JR, Baudet A (1993): Estradiol is selectively neurotoxic to hypothalamic β-endorphin neurons. Endocrinology 132:86-93.
10. Desjardins GC, Beaudet A, Meaney MJ, Brawer JR (1995): Estrogen-induced hypothalamic beta-endorphin neuron loss: a possible model of hypothalamic aging. Exp Gerontol 30:253-267.
11. Dodt C, Dittman J, Hruby J, Späth-Schwalbe E, Born J, Schüttler R, et al (1991): Different regulation of adrenocorticotropin and cortisol secretion in young, mentally healthy elderly and patients with senile dementia of Alzheimer's type. J Clin Endocrinol Metab 72:272-276.
12. Edwards CR, Walker BR, Benediktsson R, Seckl JR (1993): Congenital and aquired syndromes of apparent mineralocorticoid excess. J Steroid Biochem Mol Biol 45:1-5.
13. Flood JF, Morley JE, Roberts E (1992): Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc Natl Acad Sci USA 89:1567-1571.
14. Folstein MF, Folstein SE, McHugh PR (1975): "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198.
15. Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, Mc Allister VL, Marshall J, et al (1975): Cerebral blood flow in dementia. Arch Neurol 32:632-637.
16. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982): A new clinical scale for the staging of dementia. Br J Psychiatry 140:566-572.
17. Islam A, Henriksson B, Mohammed A, Winblad B, Adem A (1995): Behavioural deficits in adult rats following long-term adrenalectomy. Neurosci Lett 194:49-52.
18. 1-24) stimulation in major depression. Arch Gen Psychiatry 44:233-240.
19. Lesch KP, Ihl R, Fröhlich L, Rupprecht R, Müller U, Schulte HM, et al (1990): Endocrine responses to growth hormone releasing hormone and corticotropin releasing hormone in early-onset Alzheimer's disease. Psychiatry Res 33:107-112.
20. Linder J, Nolgård P, Näsman B, Bäck O, Uddhammar A, Olsson T (1993): Decreased peripheral glucocorticoid sensitivity in Alzheimer's disease. Gerontology 39:200-206.
21. Maeda K, Tanimoto K, Terada T, Shintani T, Kakigi T (1991): Elevated urinary free cortisol in patients with dementia. Neurobiol Aging 12:161-163.
22. Maehlen J, Torvik A (1990): Necrosis of granule cells of hippocampus in adrenocortical failure. Acta Neuropathol Berl 80:85-87.
23. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984): Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group. Neurology 34:939-944.
24. Mellon SH (1994): Neurosteroids: biochemistry, modes of action, and clinical relevance. J Clin Endocrinol Metab 78: 1003-1008.
25. Miller AH, Sastry G, Speranza AJ, Lawlor BA, Mohs RC, Ryan TM, et al (1994): Lack of association between cortisol hypersecretion and nonsuppression on the DST in patients with Alzheimer's disease. Am J Psychiatry 151:267-270.
26. Montgomery SA, Åsberg M (1979): A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382-389.
27. Näsman B, Olsson T, Bäckström T, Eriksson S, Grankvist K, Viitanen M, et al (1991): Serum dehydroepiandrosterone sulphate in Alzheimer's disease and multi-infarct dementia. Biol Psychiatry 30:684-690.
28. Näsman B, Olsson T, Viitanen M, Carlström K (1995a): A subtle disturbance in the feed back regulation of the hypothalamic-pituitary-adrenal axis in the early phase of Alzheimer's disease. Psychoneuroendocrinology 20:211-220.
29. Näsman B, Olsson T, Seckl JR, Eriksson S, Viitanen M, Bucht G, et al (1995b): Abnormalities in adrenal androgens, but not of glucocorticoids, in early Alzheimer's disease. Psychoneuroendocrinology 20:83-94.
30. Näsman B, Olsson T, Fagerlund M, Eriksson S, Viitanen M, Carlström K (1996): Blunted adrenocorticotropin and increased adrenal steroid response to human corticotropin-releasing hormone in Alzheimer's disease. Biol Psychiatry 39:311-318.
31. O'Brien JT, Schweitzer I, Ames D, Mastwyk M, Colman P (1994): The function of the hypothalamic-pituitary-adrenal axis in Alzheimer' s disease. Response to hypoglycaemia. Br J Psychiatry 165:650-657.
32. O'Brien JT, Ames D, Schweitzer I, Mastwyk M, Colman P (1996): Enhanced adrenal sensitivity to adrenocorticotrophic hormone (ACTH) is evidence of HPA axis hyperactivity in Alzheimer's disease. Psychol Med 26:7-14.
33. Österlind PO (1993): Medical and social conditions in the elderly, gender and age differences. The Umeå longitudinal study. Thesis. University of Umeå, Sweden.
34. Parker LN (1989): Adrenal Androgens in Clinical Medicine. San Diego: Academic Press, Inc.
35. Rasmuson S, Olsson T, Hägg E (1996): A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol 44:151-156.
36. Roberts E, Bologa L, Flood JF, Smith GE (1987): Effects of dehydroepiandrosterone and its sulfate on brain tissue in culture and on memory in mice. Brain Res 406:357-362.
37. Roberts E, Fitten LJ (1990): The Biological Role of Dehydroepiandrosterone (DHEA). Berlin: De Gruyter, pp 43-63.
38. Rudman D, Shetty KR, Mattson DE (1990): Plasma dehydroepiandrosterone sulfate in nursing home men. J Am Geriatr Soc 38:421-427.
39. Sapolsky RM (1992): Stress, the Aging Brain, and the Mechanisms of Neuron Death. Cambridge: MIT Press.
40. Schneider LS, Hinsey M, Lyness S (1992): Plasma dehydroepiandrosterone sulfate in Alzheimer's disease. Biol Psychiatry 31:205-208.
41. Seckl JR, French KL, O'Donell D, Meaney MJ, Nair NPV, Yates C, et al (1993): Glucocorticoid receptor gene expression is unaltered in hippocampal neurons in Alzheimer's disease. Mol Brain Res 18:239-245.
42. Stege R, Eriksson A, Henriksson P, Carlström K (1987): Orchidectomy or oestrogen treatment in prostatic cancer: Effects on serum levels of adrenal androgens and related steroids. Int J Androl 10:581-587.
43. Sunderland T, Merril CR, Harrington MG, Lawlor BA, Molchan SE, Martinez R, Murphy DL (1989): Reduced plasma dehydroepiandrosterone concentrations in Alzheimer's disease. Lancet ii:570.
44. Tordjman K, Jaffe A, Grazas N, Apter C, Stern N (1995): The role of the low dose (1 μg) adrenocorticotropin test in the evaluation of patients with pituitary diseases. J Clin Endocrinol Metab 80:1301-1305.
45. Wilkinson L (1988): SYSTAT: The System for Statistics. Evanston: SYSTAT Inc.